Company profile: Solis Mammography
1.1 - Company Overview
Company description
- Provider of women's breast imaging and care services, including 3D and screening mammography, diagnostic mammograms and imaging, breast ultrasound and biopsy, bone density screenings, and a Breast Care Coordination program. Offers Mammo+Plus, an AI-based tool that calculates one-year breast cancer risk using mammogram images, age, and breast density.
Products and services
- Screening Mammograms: Clinical-grade annual breast screening exams architected for early detection, recommended for women aged 40+ or higher-risk, enabling routine baseline imaging and timely identification of suspicious changes
- 3D Mammography: X-ray-based 3D mammography creates a three-dimensional breast picture from multiple images, improving detection of abnormalities and delivering detailed visualization during dedicated breast imaging examinations
- Diagnostic Services: Diagnostic-grade diagnostic services encompass diagnostic mammograms and other imaging to investigate breast abnormalities detected during screening or physical exams, offering targeted evaluation of suspicious areas
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Solis Mammography
PBM Labs
HQ: United States
Website
- Description: Provider of physician-owned, independent pathology laboratory services serving North Texas for more than 50 years, delivering technical, professional, consultative, and managerial pathology support. Offerings include anatomic pathology (histopathology, cytology, immunohistochemistry, forensic), renal diagnostics (native/transplant biopsies, 24-hour microscopy turnaround), hematopathology, flow cytometry, autopsy, and consultative services after-hours, weekends, and holidays.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PBM Labs company profile →
MediSupport
HQ: Switzerland
Website
- Description: Provider of services operating in 10 cities in Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MediSupport company profile →
ClearPath Diagnostics
HQ: United States
Website
- Description: Provider of laboratory diagnostic services, offering Digene Hybrid Capture 2 testing for human papilloma virus (HPV), testing for GC and Chlamydia, diagnostic services for various tissue specimens for health care providers and their patients, supplemental tissue diagnostics including immunohistochemistry, and frozen section analysis services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClearPath Diagnostics company profile →
Poplar Healthcare
HQ: United States
Website
- Description: Provider of specialized laboratory testing services through its GI Pathology, D-PATH Dermatopathology, OncoMetrix, UroPath Diagnostics, and Women’s Health Laboratories brands, serving a nationwide client base of gastroenterologists, dermatologists, oncologists, and urologists.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Poplar Healthcare company profile →
Diagnosticum
HQ: Germany
Website
- Description: Provider of clinical-chemical laboratory services delivering diagnostical studies with a focus on the application of pharmacogenetic information services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Diagnosticum company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Solis Mammography
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Solis Mammography
2.2 - Growth funds investing in similar companies to Solis Mammography
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Solis Mammography
4.2 - Public trading comparable groups for Solis Mammography
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →